VIVS

2.04

4.62% 0.09

Dopo l'orario di chiusura: 2.04

Vivosim Labs Inc (VIVS)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

$1.95

Aprire:

$1.97

Volume 24 ore:

45,177

Relative Volume:

0.10

Capitalizzazione di mercato:

$5.32M

Reddito:

Utile/perdita netta:

Rapporto P/E:

EPS:

Flusso di cassa netto:

1 W Prestazione:

+12.09%

1M Prestazione:

-12.07%

6M Prestazione:

+29.94%

1 anno Prestazione:

+0.00%

Intervallo 1D:

$1.91

$2.05

Intervallo di 1 settimana:

$1.7425

$2.05

Portata 52W:

$1.41

$5.30

Vivosim Labs Inc Stock (VIVS) Company Profile

Nome

Vivosim Labs Inc

Settore

Healthcare (1114)

Industria

Biotechnology (625)

Telefono

858-224-1000

Indirizzo

11555 SORRENTO VALLEY ROAD, SAN DIEGO

Dipendente

Cinguettio

Prossima data di guadagno

Ultimi documenti SEC

VIVS's Discussions on Twitter

Confronta VIVS con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
VIVS Vivosim Labs Inc	2.04	5.09M	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	468.38	113.87B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	776.54	80.22B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	406.40	52.56B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	803.74	49.31B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	175.07	37.37B	447.02M	-1.18B	-906.14M	-6.1812

Vivosim Labs Inc Stock (VIVS) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2018-12-13	Iniziato	H.C. Wainwright	Buy
2017-11-10	Downgrade	Raymond James	Outperform → Mkt Perform
2017-01-25	Iniziato	Raymond James	Outperform
2015-08-11	Downgrade	Cantor Fitzgerald	Buy → Hold
2015-06-29	Iniziato	Jefferies	Buy
2015-06-29	Iniziato	Piper Jaffray	Overweight

Mostra tutto

Vivosim Labs Inc Borsa (VIVS) Ultime notizie

Jan 06, 2026

VivoSim Labs appoints Amar Sethi, M.D., Ph.D. as chief scientific officer - marketscreener.com

Jan 06, 2026

VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer - The Manila Times

Jan 06, 2026

VivoSim Labs appoints Amar Sethi as chief scientific officer By Investing.com - Investing.com India

Jan 06, 2026

Is VivoSim Labs Inc. (4OR) stock a top dividend aristocrat candidate2026 world cup usa national team quarterfinals top scorers build up play match prediction breakdown - Улправда

Jan 06, 2026

Is VivoSim Labs Inc. stock positioned for long term growth2026 world cup usa national team group stage top scorers high defensive line tactical prediction statistical analysis - Улправда

Jan 06, 2026

Dec 26, 2025

Target’s SoHo Store Opens Amid Strategic Expansion Efforts - StocksToTrade

Dec 26, 2025

Dec 20, 2025

Is VivoSim Labs Inc. stock affected by interest rate hikes2025 Dividend Review & Technical Entry and Exit Tips - Улправда

Dec 20, 2025

VivoSim Labs (NASDAQ:VIVS) Shares Up 2.6% – Should You Buy? - Defense World

Dec 20, 2025

Merger Talk: Why retail investors favor VivoSim Labs Inc. stockMarket Rally & Technical Analysis for Trade Confirmation - Улправда

Dec 20, 2025

Dec 19, 2025

Why retail investors favor VivoSim Labs Inc. stockJuly 2025 PostEarnings & Target Return Focused Picks - Улправда

Dec 19, 2025

Earnings Update: Why retail investors favor VivoSim Labs Inc. stockTrade Exit Summary & Low Drawdown Momentum Trade Ideas - Улправда

Dec 19, 2025

US Stocks Recap: Why VivoSim Labs Inc. stock could outperform in 2025Day Trade & Verified Technical Trade Signals - Улправда

Dec 19, 2025

Dec 18, 2025

Amar Akhtar Sethi Net Worth (2025) - GuruFocus

Dec 18, 2025

Trade Recap: Will VivoSim Labs Inc. stock benefit from automationGlobal Markets & High Win Rate Trade Tips - ulpravda.ru

Dec 18, 2025

Buyback Watch: Is VivoSim Labs Inc. stock attractive after correctionWeekly Market Report & Stepwise Entry/Exit Trade Alerts - Улправда

Dec 18, 2025

VivoSim Labs Stockholders Approve Directors and Governance Matters - TipRanks

Dec 18, 2025

Why VivoSim Labs Inc. stock could outperform in 2025Trade Volume Summary & Long-Term Safe Investment Ideas - Улправда

Dec 18, 2025

Is VivoSim Labs Inc. stock undervalued vs historical averagesJuly 2025 Selloffs & Free Growth Oriented Trading Recommendations - Улправда

Dec 18, 2025

Will VivoSim Labs Inc. stock benefit from automationPortfolio Value Summary & Verified Entry Point Detection - Улправда

Dec 18, 2025

Dec 12, 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Dec 12, 2025

Dec 04, 2025

Can VivoSim Labs Inc. (4OR) stock stage a strong rebound this quarter2025 Risk Factors & Expert Approved Trade Ideas - Newser

Dec 04, 2025

How VivoSim Labs Inc. (4OR) stock reacts to monetary easingJuly 2025 Short Interest & Long-Term Growth Plans - Newser

Dec 04, 2025

What valuation ratios show for VivoSim Labs Inc. (4OR) stockJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - Newser

Dec 04, 2025

Can VivoSim Labs Inc. (4OR) stock hit consensus price targetsQuarterly Portfolio Summary & Technical Confirmation Trade Alerts - Newser

Dec 04, 2025

Will VivoSim Labs Inc. (4OR) stock beat international competitionQuarterly Performance Summary & Low Risk High Win Rate Stock Picks - Newser

Dec 04, 2025

How interest rate cuts could boost VivoSim Labs Inc. stockMarket Sentiment Summary & Proven Capital Preservation Methods - Newser

Dec 04, 2025

Dec 03, 2025

What consensus target says about VivoSim Labs Inc. (4OR) stockPortfolio Value Report & Verified Chart Pattern Signals - Newser

Dec 03, 2025

Dec 02, 2025

VivoSim Labs (VIVS) Competitors and Alternatives 2025 - MarketBeat

Dec 02, 2025

Will VivoSim Labs Inc. (4OR) stock beat revenue estimatesEarnings Growth Report & Real-Time Volume Analysis - Newser

Dec 02, 2025

Will VivoSim Labs Inc. (4OR) stock split increase liquidity - Newser

Dec 02, 2025

Nov 29, 2025

Momentum Shift: Is VivoSim Labs Inc. stock a safe investment in uncertain marketsWeekly Volume Report & Consistent Growth Stock Picks - moha.gov.vn

Nov 29, 2025

Nov 21, 2025